Massive hemoptysis successfully treated with extracorporeal membrane oxygenation and endobronchial thrombolysis

Rev Bras Ter Intensiva. 2018 Mar;30(1):116-120. doi: 10.5935/0103-507x.20180002. Epub 2018 Mar 1.
[Article in English, Portuguese]

Abstract

Extracorporeal membrane oxygenation has been used to treat refractory hypoxemia in numerous clinical scenarios. The fundamental principles for the management of massive hemoptysis patients include protecting the airway and healthy lung, locating the source of bleeding and controlling the hemorrhage. We report the case of a patient with acute respiratory failure associated with massive hemoptysis secondary to lung laceration during cardiac surgery. The use of extracorporeal membrane oxygenation allowed patient survival. However, due to the great difficulty in managing pulmonary clots after hemoptysis, it was necessary to use an unusual therapy involving endobronchial infusion of a thrombolytic agent as described in rare cases in the literature.

Publication types

  • Case Reports

MeSH terms

  • Acute Disease
  • Cardiac Surgical Procedures / adverse effects
  • Extracorporeal Membrane Oxygenation / methods*
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Hemoptysis / etiology
  • Hemoptysis / therapy*
  • Humans
  • Middle Aged
  • Postoperative Complications / physiopathology
  • Postoperative Complications / therapy
  • Respiratory Insufficiency / etiology
  • Respiratory Insufficiency / therapy

Substances

  • Fibrinolytic Agents